Overview

Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine

Status:
Completed

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate differences in the pharmacokinetics and pharmacodynamics of ticagrelor and its active metabolite between patients who received ticagrelor and morphine followed by naloxone versus patients treated with ticagrelor and morphine alone for unstable angina pectoris.

Phase:

Phase 4

Details

Lead Sponsor:

Collegium Medicum w Bydgoszczy

Treatments:

Morphine
Naloxone
Ticagrelor